Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Donald Benjamin Sanders

Donald Benjamin Sanders

Professor of Neurology
DUKE UNIVERSITY SCHOOL OF MEDICINE ,USA
USA

Biography

Donald Benjamin Sanders is a distinguished Professor of Neurology specializing in Neuromuscular Diseases at Duke University Medical Center in Durham, NC. Dr. Sanders is renowned for his expertise in neuromuscular medicine and has been instrumental in advancing the field through his extensive research and clinical practice.

Dr. Sanders completed his medical education at Harvard University, obtaining his M.D. in 1964. He has since dedicated his career to studying and treating neuromuscular disorders, particularly focusing on myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS). As the director of the Neuromuscular Medicine/EMG Fellowship Program at Duke University, he mentors and educates future leaders in the field.

Throughout his career, Dr. Sanders has been involved in numerous groundbreaking research projects and clinical trials aimed at improving therapies for neuromuscular diseases. His research interests encompass the immunologic and neuromuscular facilitating agents for MG and LEMS, and he has received multiple grants to support his research endeavors.

Dr. Sanders has authored and co-authored numerous publications in prestigious journals, contributing significantly to the understanding and treatment of neuromuscular disorders. He is a sought-after speaker at national and international conferences, where he shares his expertise and insights with colleagues and peers.

Research Interest

Dr. Sanders's research interests primarily focus on two main areas: the therapy of neuromuscular diseases, particularly exploring immunologic and neuromuscular facilitating agents for myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS); and conducting clinical trials in nerve, muscle, and neuromuscular diseases. His work aims to improve treatment outcomes and quality of life for patients with these challenging conditions through innovative therapeutic approaches and rigorous scientific investigation.